ACA exchange enrollment falls short of projections for 2017

Some 12.2 million people purchased health insurance through the Affordable Care Act (ACA) exchanges in the last open enrollment period, half a million fewer than in the 2016 and well below the 13.8 million projected by HHS under the Obama administration.

Previous figures released by CMS showed enrollment on the federally facilitated marketplace, Healthcare.gov, had declined from 9.6 million to 9.2 million enrollees this year. The updated figures include numbers from state-run exchanges, some of which did have more higher enrollment individually, but overall enrollment on state marketplaces declined by 100,000, to 3 million customers for 2017.

Of the 12.2 million who signed up, about 3.8 million were new customers, 5.2 million were active re-enrollees who picked another plan and nearly 2.8 million were automatically re-enrolled.

The number of new enrollees are one of several areas which fall short of what Obama’s HHS had projected. It had expected 4.6 million new customers along with 9.2 million returning ones. Despite publicized efforts to recruit more young people to improve the exchanges’ risk pool, only 27 percent (3.3 million) of enrollees were between 18 and 34 years old, down slightly from the group’s 28 percent share in prior open enrollment periods.

Some of that drop-off may be attributed to the Trump administration’s move to pull TV ads in the final days of open enrollment, with younger customers tending to make up most of those last-minute shoppers.

Less optimistic analysts were closer to predicting the final numbers. Standard and Poor’s had estimated total enrollment for 2017 would fall between 11.7 million and 13.3 million.

For 2018, open enrollment could go much differently. For one, the Trump administration has proposed cutting the period in half, ending it on Dec. 15 rather than Jan. 31. Additionally, more insurers could opt out of participating on the exchanges with the proposed American Health Care Act (AHCA) allowing customers to use tax credits on off-exchange coverage. 

""
John Gregory, Senior Writer

John joined TriMed in 2016, focusing on healthcare policy and regulation. After graduating from Columbia College Chicago, he worked at FM News Chicago and Rivet News Radio, and worked on the state government and politics beat for the Illinois Radio Network. Outside of work, you may find him adding to his never-ending graphic novel collection.

Around the web

The tirzepatide shortage that first began in 2022 has been resolved. Drug companies distributing compounded versions of the popular drug now have two to three more months to distribute their remaining supply.

The 24 members of the House Task Force on AI—12 reps from each party—have posted a 253-page report detailing their bipartisan vision for encouraging innovation while minimizing risks. 

Merck sent Hansoh Pharma, a Chinese biopharmaceutical company, an upfront payment of $112 million to license a new investigational GLP-1 receptor agonist. There could be many more payments to come if certain milestones are met.